Emergent BioSolutions
EBS
#8266
Rank
A$0.48 B
Marketcap
A$9.48
Share price
6.13%
Change (1 day)
-20.75%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): A$88.44 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.64 Billion. In 2025 the company made an earning of A$0.19 Billion, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$88.44 M-55.67%
2025 A$0.19 B-297.64%
2024 -A$0.11 Billion-88.82%
2023 -A$0.91 Billion242.73%
2022 -A$0.27 Billion-153.8%
2021 A$0.48 B-20.43%
2020 A$0.61 B278.02%
2019 A$0.16 B27.11%
2018 A$0.12 B-27.12%
2017 A$0.17 B17.21%
2016 A$0.15 B0.45%
2015 A$0.14 B73.51%
2014 A$86.07 M41.36%
2013 A$60.89 M35.2%
2012 A$45.03 M0.4%
2011 A$44.85 M-56.46%
2010 A$0.10 B76.73%
2009 A$58.29 M32.94%
2008 A$43.85 M-5.62%
2007 A$46.46 M
2005 A$67.27 M269.89%
2004 A$18.18 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.87 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.46 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.05 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$16.44 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$28.97 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.18 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel